In the three lung tumor models examined, PON2 expression in subcutaneously or orthotopically transplanted tumors and primary lung adenocarcinoma driven by oncogenic Kras as well as in host mice failed to significantly impact the initiation and development of tumors. Here, KRAS is linked to lung adenocarcinoma.